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Systolic anterior motionLeft ventricular outﬂow tract (LVOT) obstruction can be
frequently seen in patients with hypertrophic cardiomyopathy
(HCM). Maron et al. reported that 37% of HCM patients had LVOT
obstruction with peak systolic gradient at rest 50 mmHg
[1]. Surprisingly, they also reported that an additional 33% of
HCM patients had provocable LVOT obstruction with exercise, that
is, a total of 70% of the patients had LVOT obstruction at rest or with
exercise. Patients with obstructive HCM show mitral valve systolic
anterior motion (SAM) that is determined largely by the
interrelation of LVOT geometry, the size and mobility of the
mitral leaﬂets, and the presence and distribution of ﬁbrous
thickening [2]. In addition, both Venturi and drag forces also play
a role in inducing mitral valve SAM and the following LVOT
obstruction [3,4]. It should be noted that mitral regurgitation (MR)
in varying degrees is found in obstructive HCM patients with or
without association with structural deformities of the valve
apparatus. LVOT obstruction can cause cardiovascular symptoms,
such as chest pain and dyspnea, on exertion or at rest. Syncope or
presyncope may be the consequence of arrhythmias or autonomic
disorder, but would derive from LVOT obstruction when related to
larger exertion or to swift standing [5]. Both the degree of LVOT
obstruction and the severity of symptoms are associated with the
prognosis in HCM patients [6,7]. Thus, the diagnosis of LVOT
obstruction and the treatment are important.
In this issue of the Journal of Cardiology Cases, Kim et al. present
a case with reversible severe MR caused by mitral valve SAM and
LVOT obstruction in the absence of left ventricular hypertrophy
(LVH) [8]. As described above, the most common etiology of LVOT
obstruction is HCM. However, LVOT obstruction is observed also
in hypertensive patients with the diffuse type of LVH [9,10]. In
addition, LVOT obstruction is observed also in patients even
without overt LVH [11,12]. LVOT obstruction seen in patients
without LVH is generally latent, and is observed by provocationDOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.08.005
http://dx.doi.org/10.1016/j.jccase.2015.10.013
1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightswith exercise, inotropic agents, vasodilators, or Valsalva maneuver.
In contrast, the present case demonstrated by Kim et al. had no
signiﬁcant LVH but mitral valve SAM, following LVOT obstruction
and severe MR at rest without any provocation when she was
referred to their hospital. In addition, LVOT obstruction and severe
MR were totally dynamic and disappeared after oral administra-
tion of a beta blocker. These are the unique points of the present
case.
Three factors can be raised as causes of a series of rare
abnormalities in the present case demonstrated by Kim et al. First,
the hyperadrenergic state due to heart failure could induce the LV
hyperkinetic motion that emphasized LVOT obstruction. Secondly,
basal septal bulge due to sigmoid septum could also emphasize
LVOT obstruction. It has been reported that sigmoid septum is an
important determinant of dynamic LVOT obstruction [13]. Lastly, it
can be guessed that the redundancy of mitral valve is the most
characteristic ﬁnding and can be the most important cause of
dynamic LVOT obstruction in this case. In supplementary
echocardiographic movie ﬁles in this case report, the anterior
mitral leaﬂet appears to be especially thick and redundant.
Mechanisms of LVOT obstruction are diverse among patients. As
also described in the Discussion section of this case report, not only
LV size, LV systolic function, and basal septal bulge due to true
septal hypertrophy or sigmoid septum but also papillary muscle
displacement, increased mitral leaﬂet area, and both Venturi and
drag forces were considered as contributing factors of SAM, the
following LVOT obstruction, and MR [2–4,11,12,14,15]. Preload
reduction, afterload reduction, and the hyperadrenergic state due
to exercise, inotropic agents, or worsening heart failure can modify
the LV size and contractility. It leads to dynamic deterioration of
preexisting LVOT obstruction or unmasking of latent LVOT
obstruction [1,3,10–13,15].
From this excellent case report by Kim et al., again, we should
learn that not only HCM patients or hypertensive LVH patients but
also those with sigmoid septum or mitral valve elongation can
have SAM, LVOT obstruction, and signiﬁcant MR even without
overt LVH. Also, the LVOT obstruction can dynamically change in
various clinical settings.
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